Smith & Nephew (SNN) Cash from Discontinued Operations (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Cash from Discontinued Operations of 238000000.0 for Q4 2024, up 110.62% year-on-year from 113000000.0 in Q1 2024, and up 110.62% on a QoQ basis from 113000000.0 in Q4 2023.
Smith & Nephew (SNN) Cash from Discontinued Operations (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Cash from Discontinued Operations for 16 consecutive years, with 238000000.0 the latest figure, recorded in Q4 2024.
- Quarterly Cash from Discontinued Operations rose 110.62% year-over-year to 238000000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 921000000.0 (up 21.83% YoY) and the FY2025 annual result came in at 1285000000.0, up 30.19% from the prior year.
- Cash from Discontinued Operations climbed to 238000000.0 in Q4 2024 per SNN's latest filing, from 113000000.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for SNN reached as high as 363000000.0 in Q4 2021 and fell as low as 73000000.0 in Q4 2020.
- A 5-year average of 198800000.0 and a median of 207000000.0 in 2022 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2020 — Cash from Discontinued Operations slumped 83.81% — and 2021, when it jumped 397.26%.
- Year by year, Cash from Discontinued Operations stood at 73000000.0 in 2020, then soared by 397.26% to 363000000.0 in 2021, then tumbled by 42.98% to 207000000.0 in 2022, then slumped by 45.41% to 113000000.0 in 2023, then surged by 110.62% to 238000000.0 in 2024.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 238000000.0, 113000000.0, and 207000000.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 238.00 Mn |
| Dec 31, 2024 | 238.00 Mn |
| Dec 31, 2023 | 113.00 Mn |
| Dec 31, 2023 | 113.00 Mn |
| Dec 31, 2022 | 207.00 Mn |
| Dec 31, 2022 | 207.00 Mn |
| Dec 31, 2021 | 363.00 Mn |
| Dec 31, 2021 | 363.00 Mn |
| Dec 31, 2020 | 73.00 Mn |
| Dec 31, 2020 | 73.00 Mn |
| Dec 31, 2019 | 451.00 Mn |
| Dec 31, 2019 | 451.00 Mn |
| Dec 31, 2018 | 931.00 Mn |
| Dec 31, 2018 | 931.00 Mn |
| Dec 31, 2017 | 1.09 Bn |
| Dec 31, 2017 | 1.09 Bn |
| Dec 31, 2016 | 269.00 Mn |
| Dec 31, 2016 | 269.00 Mn |
| Dec 31, 2015 | 490.00 Mn |
| Dec 31, 2015 | 490.00 Mn |